JAZZ — Jazz Pharmaceuticals plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1232524 ·
Ireland
Last close
$240.71
Market Cap
$15.45B
52W High
$266.38
52W Low
$156.95
ADV30
807,025
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,243,000,000 | 1,132,400,000 | 340,800,000 | -483,400,000 | 11,997,700,000 | 2,036,400,000 | 7,805,900,000 |
| Jun 2026 | 1,208,300,000 | 1,091,900,000 | 325,200,000 | 192,800,000 | 11,080,900,000 | 1,619,800,000 | 6,279,200,000 |
| Mar 2026 | 1,068,900,000 | 934,800,000 | 336,600,000 | 293,100,000 | 11,859,600,000 | 1,844,300,000 | 7,327,300,000 |
| Dec 2025 | 1,197,926,000 | 1,044,398,000 | 254,535,000 | 203,451,000 | 11,659,340,000 | 1,391,899,000 | 7,340,756,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,692,518,000
Investing CF
$-977,962,000
Financing CF
$-3,860,000
CapEx
$-278,429,000
Dividends Paid
—
Buybacks
$-225,000,000
EPS Diluted TTM
$2.94
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$423,600,000
Inventory
$454,000,000
Receivables
$873,700,000
ST Investments
$820,000,000
EBIT TTM
$427,677,000
Pretax Income TTM
$259,771,000
Interest Exp TTM
$167,906,000
Analysts
22
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,718,185,984
EBITDA
$2,010,866,944
Free Cash Flow
$1,681,385,344
Enterprise Value
$17,857,622,016
Total Cash
$2,856,399,872
Total Debt
$5,645,000,192
Shares Out
64,189,052
Trailing EPS
$3.38
Book Value
$65.39
ROE
5.1%
ROA
6.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,267,586,000 | 517,622,000 | -356,148,000 | 11,659,340,000 | 7,340,756,000 | 4,318,584,000 | 1,355,773,000 |
| Dec 2024 | 4,068,950,000 | 726,630,000 | 560,120,000 | 12,012,257,000 | 7,918,501,000 | 4,093,756,000 | 1,395,908,000 |
| Dec 2023 | 3,834,204,000 | 597,580,000 | 414,832,000 | 11,393,359,000 | 7,656,362,000 | 3,736,997,000 | 1,092,007,000 |
| Dec 2022 | 3,659,374,000 | 512,268,000 | -224,060,000 | 10,835,255,000 | 7,749,521,000 | 3,085,734,000 | 1,271,977,000 |
TTM Snapshot
Revenues TTM
$4,601,233,000
NetIncome TTM
$940,763,000
OpCashFlow TTM
—
Assets (Latest)
$11,080,900,000
Forward EPS
$25.99
Max Pain — expiry 2026-12-18
max pain strike: $200.00 · spot: $240.08 · call oi: 3,843 · put oi: 876
Expected Move to 2026-12-18:
±$16.55
(6.89%) —
implied range
$223.53 –
$256.63
· ATM straddle on $240.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | $14.96B | $76.80 | — |
| ASND | Ascendis Pharma A/S | $17.84B | $271.19 | — |
| ELAN | Elanco Animal Health Inc | $12.92B | $25.85 | — |
| RDY | DR REDDYS LABORATORIES LTD | $12.32B | $14.79 | — |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $20.96B | $156.50 | — |
News headlines (Yahoo Finance, 1h cache)
Don't Overlook Jazz (JAZZ) International Revenue Trends While Assessing the Stock
2026-11-09 13:15 · Yahoo
BRC Therapeutics Appoints Kimberly Spancake as Senior Director, Clinical
2026-11-05 17:12 · Yahoo
Jazz Pharmaceuticals (JAZZ) Stock Jumps On Q2 Earnings Turnaround
2026-11-03 22:20 · Yahoo
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
2026-11-03 21:15 · Yahoo
Jazz Pharmaceuticals PLC (JAZZ) (Q3 2026) Earnings Call Highlights: Record $1. ...
2026-11-03 21:02 · Yahoo
Jazz Pharmaceuticals plc Q3 2026 Earnings Call Summary
2026-11-03 13:30 · Yahoo
Jazz: Q3 Earnings Snapshot
2026-11-03 04:29 · Yahoo
Jazz (JAZZ) Q3 2026 Earnings Call Transcript
2026-11-03 04:28 · Yahoo
Jazz Pharmaceuticals (JAZZ) Will Present Phase 3 And Phase 2 Brain Cancer Data
2026-11-03 03:21 · Yahoo
Jazz Pharmaceuticals (JAZZ) Could Be 27% Undervalued As Record Revenue Lifts Outlook
2026-11-03 02:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.